Alessandra Ammazzalorso

Via Dei Vestini 31
Chieti, 66100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Synthesis, Antibacterial Evaluation, and Chemometric Profiling of a Vanilloid-Based Compounds Library Active Against Helicobacter pylori.

Synthesis, Antibacterial Evaluation, and Chemometric Profiling of a Vanilloid-Based Compounds Library Active Against Helicobacter pylori.

Journal: Antibiotics (Basel, Switzerland)
Published: May 21, 2026

Synthesis, Biological Evaluation, and Computational Study of Pyridine- and Indazole-Based Inhibitors of the Inducible Nitric Oxide Synthase as Promising Antipsoriatic Agents.

Synthesis, Biological Evaluation, and Computational Study of Pyridine- and Indazole-Based Inhibitors of the Inducible Nitric Oxide Synthase as Promising Antipsoriatic Agents.

Journal: ACS pharmacology & translational science
Published: October 27, 2025

Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer.

Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 15, 2025

Sulfonamides as Aromatase Inhibitors: Nimesulide Analogues, N-cyclic- and Aryl-Sulfonamides.

Sulfonamides as Aromatase Inhibitors: Nimesulide Analogues, N-cyclic- and Aryl-Sulfonamides.

Journal: Anti-cancer agents in medicinal chemistry
Published: May 22, 2025

Targeting PPARs in the Brain: From Old Knowledge to Emerging Therapeutic Roles.

Targeting PPARs in the Brain: From Old Knowledge to Emerging Therapeutic Roles.

Journal: CNS & neurological disorders drug targets
Published: January 21, 2025

Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry.

Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry.

Journal: Molecules (Basel, Switzerland)
Published: October 16, 2024

A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates.

A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates.

Journal: European journal of medicinal chemistry
Published: September 16, 2024

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα.

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα.

Journal: Frontiers in pharmacology
Published: August 30, 2024

Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation.

Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation.

Journal: RSC medicinal chemistry
Published: July 07, 2024

Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies.

Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 01, 2024

Recent trends and challenges to overcome Pseudomonas aeruginosa infections.

Recent trends and challenges to overcome Pseudomonas aeruginosa infections.

Journal: Expert opinion on therapeutic patents
Published: April 29, 2024

Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020-2023).

Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020-2023).

Journal: Expert opinion on therapeutic patents
Published: March 19, 2024
Showing 1-12 of 70

Last Updated: 09/26/2026